John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$175M |
| 2 |
Kroger
KR
|
+$148M |
| 3 |
Elevance Health
ELV
|
+$122M |
| 4 |
EA
Electronic Arts
EA
|
+$120M |
| 5 |
Abbott
ABT
|
+$119M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$181M |
| 2 |
Halliburton
HAL
|
+$152M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
AGN
Allergan plc
AGN
|
+$124M |
| 5 |
AutoZone
AZO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.33% |
| 2 | Technology | 13.07% |
| 3 | Consumer Discretionary | 10.5% |
| 4 | Financials | 9.32% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCH
1201
DELISTED
PotlatchDeltic
PCH
| $2.23M | 0.01% |
65,465
-194,998
| -75% | -$6.6M |
|
|
JCP
1202
DELISTED
J.C. Penney Company, Inc.
JCP
| $2.23M | 0.01% |
250,763
-1,732,534
| -87% | -$15.2M |
|
1203
Installed Building Products
IBP
$6.52B
| $2.22M | 0.01% |
+61,273
| New | +$1.9M |
|
1204
Prestige Consumer Healthcare
PBH
$2.46B
| $2.22M | 0.01% |
40,084
-6,906
| -15% | -$380K |
|
|
FLY
1205
DELISTED
Fly Leasing Limited
FLY
| $2.22M | 0.01% |
223,582
+9,885
| +5% | +$114K |
|
1206
CALL
Visa
V
$712B
| $2.22M | 0.01% |
29,900
-15,100
| -34% | -$1.18M |
|
|
KANG
1207
DELISTED
iKang Healthcare Group, Inc.
KANG
| $2.22M | 0.01% |
120,883
-112,650
| -48% | -$2.27M |
|
|
SHOR
1208
DELISTED
ShoreTel, Inc.
SHOR
| $2.21M | 0.01% |
331,041
-14,248
| -4% | -$94.4K |
|
1209
PUT
Automatic Data Processing
ADP
$112B
| $2.21M | 0.01% |
24,100
+4,100
| +21% | +$362K |
|
1210
Employers Holdings
EIG
$882M
| $2.21M | 0.01% |
76,099
+36,239
| +91% | +$1.05M |
|
1211
CALL
Marathon Petroleum
MPC
$101B
| $2.21M | 0.01% |
58,100
+41,100
| +242% | +$1.51M |
|
|
GCI
1212
DELISTED
Gannett Co., Inc
GCI
| $2.2M | 0.01% |
+159,481
| New | +$2.47M |
|
|
ELGX
1213
DELISTED
Endologix Inc
ELGX
| $2.2M | 0.01% |
17,640
-333
| -2% | -$38.3K |
|
1214
PUT
Colgate-Palmolive
CL
$73.3B
| $2.2M | 0.01% |
30,000
-6,000
| -17% | -$427K |
|
|
ANDV
1215
PUT
DELISTED
Andeavor
ANDV
| $2.19M | 0.01% |
29,300
-700
| -2% | -$55.5K |
|
|
AAN.A
1216
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $2.19M | 0.01% |
100,043
+43,709
| +78% | +$957K |
|
1217
CALL
Entergy
ETR
$50.1B
| $2.19M | 0.01% |
53,800
-48,200
| -47% | -$1.85M |
|
1218
Trupanion
TRUP
$1.31B
| $2.19M | 0.01% |
165,149
+146,050
| +765% | +$1.91M |
|
1219
Enviri
NVRI
$615M
| $2.18M | 0.01% |
328,458
-177,814
| -35% | -$1.16M |
|
1220
Synopsys
SNPS
$78.5B
| $2.18M | 0.01% |
40,297
-126,053
| -76% | -$6.32M |
|
1221
KT
KT
$9.3B
| $2.18M | 0.01% |
152,769
-251,474
| -62% | -$3.51M |
|
1222
PUT
Oneok
OKE
$59.5B
| $2.18M | 0.01% |
+45,900
| New | +$1.82M |
|
|
PARA
1223
CALL
DELISTED
Paramount Global Class B
PARA
| $2.18M | 0.01% |
40,000
+27,000
| +208% | +$1.47M |
|
1224
ITT
ITT
$18.8B
| $2.17M | 0.01% |
67,949
+24,810
| +58% | +$890K |
|
1225
Amphastar Pharmaceuticals
AMPH
$943M
| $2.17M | 0.01% |
134,745
+18,612
| +16% | +$263K |
|
Similar funds
John Overdeck's Q2 2016 Portfolio in Review
As of Q2 2016, John Overdeck held 3,523 positions worth $23.3B, up 11% from $21B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $2B of net new capital in Q2 2016, opening 779 new positions and adding to 1,113 existing holdings. Its largest new stake was Kroger: 4,100,027 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $145M trimmed.
- John Overdeck's largest Q2 2016 buy was Kroger: 4,100,027 shares worth $151M.
- John Overdeck added most to Nike in Q2 2016, an estimated $175M increase.
- John Overdeck's biggest Q2 2016 reduction was Pfizer, cutting an estimated $145M.
- John Overdeck fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $181M.
- John Overdeck's ten largest holdings make up 7.4% of its $23.3B portfolio in Q2 2016.
- John Overdeck opened 779 new positions and closed 661 in Q2 2016.
- John Overdeck's portfolio value rose 11% quarter-over-quarter to $23.3B.
Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.